Takeda Pharmaceutical Company Limited (BVMF:TAKP34)

BVMF:TAKP34 Ratios and Metrics

Market cap in millions BRL. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 5, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	289,716	258,429	217,670	257,575	212,264	318,402
Market Cap Growth	15.76%	18.73%	-15.49%	21.35%	-33.34%	28.41%
Enterprise Value	448,233	447,498	380,767	413,967	354,375	555,175
Last Close Price	93.24	85.82	65.91	77.34	-	-
PE Ratio	73.03	62.54	45.57	21.33	23.57	16.57
PS Ratio	1.85	1.47	1.54	1.68	1.52	1.95
PB Ratio	1.08	0.97	0.90	1.06	0.95	1.20
P/FCF Ratio	8.16	7.88	12.14	8.08	5.42	6.92
P/OCF Ratio	6.94	6.39	9.16	6.92	4.83	6.16
EV/Sales Ratio	3.02	2.55	2.69	2.70	2.54	3.40
EV/EBITDA Ratio	10.20	9.48	10.04	8.46	7.65	11.04
EV/EBIT Ratio	22.45	20.76	22.99	17.54	15.09	25.62
EV/FCF Ratio	12.63	13.65	21.23	12.99	9.06	12.07
Debt / Equity Ratio	0.71	0.73	0.75	0.77	0.85	0.98
Debt / EBITDA Ratio	4.09	3.96	4.57	3.79	4.07	5.16
Debt / FCF Ratio	5.37	5.94	10.10	5.81	4.81	5.64
Asset Turnover	0.29	0.31	0.29	0.30	0.27	0.25
Inventory Turnover	1.16	1.30	1.30	1.36	1.40	1.34
Quick Ratio	0.54	0.44	0.50	0.49	0.73	1.00
Current Ratio	1.19	1.01	1.11	0.97	1.21	1.53
Return on Equity (ROE)	1.50%	1.52%	2.12%	5.27%	4.24%	7.60%
Return on Assets (ROA)	2.47%	2.40%	2.15%	2.85%	2.88%	2.06%
Return on Invested Capital (ROIC)	2.76%	2.91%	4.35%	5.15%	4.82%	4.50%
Return on Capital Employed (ROCE)	4.70%	4.80%	3.90%	5.40%	5.40%	3.80%
Earnings Yield	1.37%	1.60%	2.20%	4.69%	4.24%	6.04%
FCF Yield	12.25%	12.69%	8.24%	12.37%	18.44%	14.44%
Dividend Yield	3.02%	8.74%	9.46%	8.87%	-	-
Payout Ratio	277.04%	280.28%	199.34%	88.14%	123.30%	75.36%
Buyback Yield / Dilution	-0.25%	-1.58%	-0.67%	0.46%	-0.23%	-0.47%
Total Shareholder Return	2.77%	7.16%	8.79%	9.33%	-0.23%	-0.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.